Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00182858
Other study ID # 999903322
Secondary ID 03-AG-N322
Status Recruiting
Phase
First received
Last updated
Start date June 26, 2003
Est. completion date December 31, 2028

Study information

Verified date May 20, 2024
Source National Institutes of Health Clinical Center (CC)
Contact Denise L Melvin, R.N.
Phone (410) 350-3924
Email melvinde@mail.nih.gov
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The need to obtain human tissue for methods development and disease correlation is frequent in Biomedical Research Center laboratories. This protocol is designed to create the opportunity to obtain such tissue samples including: blood, urine, saliva, sweat, feces, hair and nail clippings, nasal scraping, muscle, fat, skin and taste buds. It may also include samples taken during a surgical procedure, including: fluid from around the spinal column, heart, lungs and abdomen; fat, muscle, connective tissue and organs (liver, bladder, heart, kidney and skin). Information derived from such studies is for research purposes only and is not provided to the participants or their health care provider. Samples will be coded (no names) and identifying information linking the participant to the sample will be maintained in a secure location by the P.I. and Study Coordinator. Participants will be 18 years or older and have been identified by the investigator and/or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of creating information that leads to scientifically useful and important studies. Participants could also be healthy volunteers, willing to provide their samples. These samples could be requested by an investigator to be used as age, gender, race and/or ethnicity-matched controls or to calibrate or compare and contrast across lab equipment. Participants will be excluded if obtaining the sample would be over and above usual clinical care, would result in excessive blood loss, or the individual is unable to provide informed consent. The expected outcome is to provide investigators with the opportunity to obtain tissues of interest for laboratory evaluation....


Description:

The need to obtain human tissue for methods development and disease correlation is frequent in Biomedical Research Center laboratories. This protocol is designed to create the opportunity to obtain such tissue samples including: blood, urine, saliva, sweat, feces, hair and nail clippings, nasal scraping, muscle, fat, skin and taste buds. It may also include samples taken during a surgical procedure, including: fluid from around the spinal column, heart, lungs and abdomen; fat, muscle, connective tissue and organs (liver, bladder, heart, kidney and skin). Information derived from such studies is for research purposes only and is not provided to the participants or their health care provider. Samples will be coded (no names) and identifying information linking the participant to the sample will be maintained in a secure location by the P.I. and Study Coordinator. Participants will be 18 years or older and have been identified by the investigator and/or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of creating information that leads to scientifically useful and important studies. Participants could also be healthy volunteers, willing to provide their samples. These samples could be requested by an investigator to be used as age, gender, race and/or ethnicity-matched controls or to calibrate or compare and contrast across lab equipment. Participants will be excluded if obtaining the sample, would result in excessive blood loss, or the individual is unable to provide informed consent. The expected outcome is to provide investigators with the opportunity to obtain tissues of interest for laboratory evaluation.


Other known NCT identifiers
  • NCT01927796

Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date December 31, 2028
Est. primary completion date December 31, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility - INCLUSION CRITERIA: - Age 18 or older. - Identified by the investigator , researcher, or physician to have a condition of interest for exploratory studies related to the participant s illness or other feature that offers the possibility of generation of hypotheses for future study. - Healthy volunteers, willing to provide their samples. EXCLUSION CRITERIA: - The participant would be subjected to diagnostic and/or therapeutic procedures that are not necessary for clinical management. - Excessive blood loss if this phlebotomy plus other research participation and/or clinical evaluation will result in blood loss of greater than 1 unit (400 ml, 1 pint) over an 8-week period. - Inability to give informed consent.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Institute of Aging, Clinical Research Unit Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Provide the investigators the opportunity to obtain tissues for laboratory evaluation with the goal of either better understanding a disease or design a scientific study to better understand or treat a disease. The goal is to assist in either the better understanding of a disease or to design a scientific study to better understand or treat a disease. Ongoing
See also
  Status Clinical Trial Phase
Completed NCT02922933 - A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects Phase 1
Completed NCT02922946 - Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat Phase 1
Completed NCT01250197 - Formulation Comparison in Normal Volunteers Phase 1
Completed NCT02051517 - Vitreous Chemistry Analysis N/A
Completed NCT01185418 - Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer N/A
Completed NCT02828813 - Neural Mechanisms of Motor and Cognitive Networks
Completed NCT02146391 - Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal Phase 1
Terminated NCT00465842 - Protein Biomarker in Hepatocellular Carcinoma
Recruiting NCT02471352 - Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Terminated NCT01752231 - Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring N/A
Completed NCT02517307 - Fatty Acid Oxidation Defects and Insulin Sensitivity N/A
Completed NCT01366352 - Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets Phase 1
Not yet recruiting NCT01487486 - Proteomics & Glyco-Proteomic Analysis of Follicular Fluid N/A
Completed NCT03993587 - The Effect of Head and Shoulder Positioning on the Cross-sectional Area of the Subclavian Vein in Obese Adults
Completed NCT02860351 - The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein. N/A
Completed NCT02113943 - Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation Phase 2